GBS is not a single disease but a spectrum of disorders. The major subtypes include: Acute Inflammatory Demyelinating Polyneuropathy (AIDP): The most common form in Western countries ...

CIDP, although less rare and not considered an acute condition ... by Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), Multifocal Motor Neuropathy ...

I will also consider the focal diabetic neuropathies, and discuss the diagnosis of chronic inflammatory demyelinating polyneuropathy ... genetically determined. Acute painful neuropathy with ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a long-term neurological disorder that targets your body’s nerves. Anyone can get CIDP, but it’s most common in older adults and ...

Netherlands biotech Argenx has a second FDA approval for its FcRn inhibitor Vyvgart Hytrulo, adding a new indication in chronic inflammatory demyelinating polyneuropathy (CIDP) for a drug that it ...

The ADHERE trial was a multicenter, randomized, double-blind, placebo-controlled trial evaluating SC efgartigimod alfa for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

The GBS | CIDP Foundation International is making strides to increase awareness of Guillain-Barré Syndrome (GBS), Chronic ...